Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients. a Phase 2, Randomized, Doble Blind, Control Trial

NCT06795698 is registered in ClinicalTrials.gov with Hospital Civil de Guadalajara as lead sponsor.

NCT NCT06795698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients. a Phase 2, Randomized, Doble Blind, Control Trial
Lead sponsor
Hospital Civil de Guadalajara
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2019
Completion date
December 1, 2024
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-induced bleeding, ckd stage 3, ckd stage 4, ckd stage 5, enoxaparin adverse reaction, fractures, bone, thromboses, venous